These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18268093)

  • 1. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
    Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
    Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S; Meri S; Jokiranta TS
    Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
    Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
    Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
    Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
    J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
    Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
    J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
    Ståhl AL; Kristoffersson A; Olin AI; Olsson ML; Roodhooft AM; Proesmans W; Karpman D
    Mol Immunol; 2009 Jul; 46(11-12):2236-43. PubMed ID: 19446882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
    Roumenina LT; Roquigny R; Blanc C; Poulain N; Ngo S; Dragon-Durey MA; Frémeaux-Bacchi V
    Methods Mol Biol; 2014; 1100():237-47. PubMed ID: 24218264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-associated complement factor H in healthy persons and patients with atypical HUS.
    Licht C; Pluthero FG; Li L; Christensen H; Habbig S; Hoppe B; Geary DF; Zipfel PF; Kahr WH
    Blood; 2009 Nov; 114(20):4538-45. PubMed ID: 19704120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
    Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
    J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.
    Roumenina LT; Jablonski M; Hue C; Blouin J; Dimitrov JD; Dragon-Durey MA; Cayla M; Fridman WH; Macher MA; Ribes D; Moulonguet L; Rostaing L; Satchell SC; Mathieson PW; Sautes-Fridman C; Loirat C; Regnier CH; Halbwachs-Mecarelli L; Fremeaux-Bacchi V
    Blood; 2009 Sep; 114(13):2837-45. PubMed ID: 19584399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.
    Ueda Y; Miwa T; Gullipalli D; Sato S; Ito D; Kim H; Palmer M; Song WC
    J Am Soc Nephrol; 2018 Jul; 29(7):1928-1937. PubMed ID: 29858280
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor H binds to washed human platelets.
    Vaziri-Sani F; Hellwage J; Zipfel PF; Sjöholm AG; Iancu R; Karpman D
    J Thromb Haemost; 2005 Jan; 3(1):154-62. PubMed ID: 15634279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
    Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
    Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
    Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
    J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.
    Pérez-Caballero D; González-Rubio C; Gallardo ME; Vera M; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Am J Hum Genet; 2001 Feb; 68(2):478-84. PubMed ID: 11170895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.